Ärzte sollen Einrichtungen den Opioid-Antagonisten Naloxon verordnen dürfen Berlin – Das Bundesgesundheitsministerium (BMG) will langjährigen Forderungen aus der Drogen- und Suchthilfe nachkommen und den Zugang zum Opioid-Antagonisten Naloxon erlei…

Reversal of a synthetic opioid overdose: Insights from a validated translational model.  Laffont CM, Purohit P, de la Peña A, Skolnick P.  Neuropharmacology. 2025 Jun 6;278:110546. doi: 10.1016/j.neuropharm.2025.110546. Epub ahead of pri…

Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? Indivior PLC, the pharmaceutical company that manufactures the opioid overdose antidote Opvee (nalmefene), has published new research showing that its product performed favorably…

Naloxone Saturation Policy Academy Retrospective Report  Report summarizes the materials from the Naloxone Saturation Policy Academies (NSPA) three cohorts of 26 states, DC, and Puerto Rico into a single summary report that can be shared with…

You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears.  Morgan, J.R. and Walley, A.Y. (2025),  Addiction. doi.org/10.1111/add.70101 https://onlinelibrary.wiley.com/doi/full/10.1111…

Missouri naloxone distribution 2017-2023: Evaluation and implications of applying a naloxone saturation model.  Vance K, Park B, Kondai R, Green L, Green TC, Marshall BDL, Winograd RP.  J Subst Use Addict Treat. 2025 May 2;174:209708. do…